ADAM-17: a novel therapeutic target for triple negative breast cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ADAM-17: a novel therapeutic target for triple negative breast cancer
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 24, Issue 2, Pages 362-369
Publisher
Oxford University Press (OUP)
Online
2012-09-12
DOI
10.1093/annonc/mds279
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Src: a potential target for the treatment of triple-negative breast cancer
- (2011) D. Tryfonopoulos et al. ANNALS OF ONCOLOGY
- Dual Blockade of EGFR and c-Met Abrogates Redundant Signaling and Proliferation in Head and Neck Carcinoma Cells
- (2011) H. Xu et al. CLINICAL CANCER RESEARCH
- Synthetic Lethality through Combined Notch-Epidermal Growth Factor Receptor Pathway Inhibition in Basal-Like Breast Cancer
- (2010) Y. Dong et al. CANCER RESEARCH
- Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer Cells
- (2010) F. Hochgrafe et al. CANCER RESEARCH
- Use of molecular markers for predicting therapy response in cancer patients
- (2010) Michael J. Duffy et al. CANCER TREATMENT REVIEWS
- Chemotherapy-Induced Activation of ADAM-17: A Novel Mechanism of Drug Resistance in Colorectal Cancer
- (2010) J. N. Kyula et al. CLINICAL CANCER RESEARCH
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of ADAMs in Cancer Formation and Progression
- (2009) M. J. Duffy et al. CLINICAL CANCER RESEARCH
- EGFR ligands and their signaling scissors, ADAMs, as new molecular targets for anticancer treatments
- (2009) Hiromi Kataoka JOURNAL OF DERMATOLOGICAL SCIENCE
- Selective Use of ADAM10 and ADAM17 in Activation of Notch1 Signaling
- (2009) E. C. Bozkulak et al. MOLECULAR AND CELLULAR BIOLOGY
- Invasive ductal carcinoma of the breast with the “triple-negative” phenotype: prognostic implications of EGFR immunoreactivity
- (2008) Giuseppe Viale et al. BREAST CANCER RESEARCH AND TREATMENT
- Characterisation of breast cancer cell lines and establishment of a novel isogenic subclone to study migration, invasion and tumourigenicity
- (2008) Linda Hughes et al. CLINICAL & EXPERIMENTAL METASTASIS
- TACE/ADAM-17: A Component of the Epidermal Growth Factor Receptor Axis and a Promising Therapeutic Target in Colorectal Cancer
- (2008) N. B. Merchant et al. CLINICAL CANCER RESEARCH
- TNF: A master switch for inflammation to cancer
- (2008) Gautam Sethi Frontiers in Bioscience-Landmark
- ERBB3/HER3 and ERBB2/HER2 Duet in Mammary Development and Breast Cancer
- (2008) David F. Stern JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started